Sentences with phrase «than their developed market»

First, emerging markets simply have more young people than developed markets.

«We'll be happy with the 1 % to 2 % growth in the developed North American markets and maintain our presence there,» says Saputo, «but we're tapping into emerging markets that are showing more growth potential than the developed markets.»

EMs currently account for more than half of the world's GDP and around two - thirds of GDP growth — that economic share is only expected to rise as EMs are projected to grow faster than developed markets (DMs) in upcoming years.

«Emerging markets are a very heterogeneous group, much more so than developed markets,» observes James Butterfill, head of research and investment strategy at London - based global investment house ETF Securities.

he says frontier and emerging markets provide ample opportunity for investors at much lower valuations than developed markets..

Like Michael, I am pretty enthusiastic about emerging markets that seem to be more progressive than the developed markets are.

Emerging markets are more volatile than developed markets and have a wider range of potential outcomes.

After the U.S. Federal Reserve decided not to raise rates on Sept. 17, emerging markets seemed poised to perform better than developed markets.

Emerging markets have higher long - term expected growth rates than developed markets, and they are more risky.

Investments in emerging or frontier markets are generally less liquid and less efficient than developed markets and are subject to additional risks, such as of adverse governmental regulation and intervention or political developments.

Emerging markets tend to be riskier than developed markets, but can also offer diversification opportunities.

I suppose you could argue that emerging markets also have a higher expected returns than developed markets, and therefore also have higher expected returns to compensate.

Are emerging markets really very much more risky than developed markets?

Emerging markets tend to be riskier than developed markets, but can also Read more -LSB-...]

They offer much - higher growth than developed markets, and therefore very compelling return prospects.

• The market with the lowest expected future return is the United States which together with Canada and Denmark promises real returns that are quite a bit lower than developed markets overall.

Anyway, I might disagree with your whole thesis, regardless — emerging markets are no more dangerous than developed markets: Yes, people always fearfully imagine losing 100 % of their investment in an emerging market — and v rarely that can happen — but they prefer to ignore the fact that in the credit crisis, on their own doorstep, they lost all their home equity, 50 % of their stock portfolio, and the rest was confiscated in taxes & unsustainable future tax / entitleement / debt burdens...

They are growing much more rapidly than developed markets.

Not exact matches

«A mature business may decide to keep replicating what it's doing» rather than entering new markets or developing new products, says Davis.

Developing and marketing custom products is a riskier, more capital - intensive business than simply importing and exporting produce.

Apple would have done better to focus on China's regional trends rather than develop the payment service for a global market, says Kitty Fok, managing director of the China group at the market research firm International Data Corporation.

The company is launching Vice Studios, a «global multi-platform scripted studio» aimed at developing original content that Vice can market around the world after the company signed content deals earlier this year to make its programming available in more than 80 territories by the end of the year.

In that vein, the company is very much a market disruptor, and this is even true in developed countries where it routinely releases Nexus phones and tablets with significantly lower prices than competitors.

They add that women who marry or expect to marry high - earners are more likely to enjoy spare time rather than use it to develop market skills.

He wants to see business improve its productivity, increase its R&D investment and grow its exports to new foreign markets — particularly to emerging markets, which for the first time in 2012 will import more goods than will the developed countries.

If you've been sitting on the sidelines of emerging markets and are ready to get back in, Jurrien Timmer, director of global macro for Fidelity Investments in Boston, recommends buying particular stocks and geographically targeted funds rather than a broad index or exchange - traded fund spanning the entire developing world.

While Fredette's job isn't always glamorous (it involves frequent meetings with the company's marketing and consumer research departments), more than 50 % of his time is spent in the kitchen, where he experiments with flavor pairings, makes ingredients, develops recipes, mixes test batches, and yes — eats a lot of ice cream.

Rather than dreaming up some novel configuration of services, successful entrepreneurs look at a given problem in a target market and develop a solution for it.

And the seemingly logical move into developing markets — where the rising middle class meant billions in new consumer spending — proved more volatile than anticipated.

Now, that's more than $ 20 of sales given away - but the offer is opening up potential sales to all those latecomers, and building up a potentially priceless presence on Foursquare as the site's full marketing potential develops.

The idea was originally developed in the early 1930s by the Russian - born economist Simon Kuznets, who was commissioned by the U.S. government to come up with a better way to measure economic activity — and guide an increasingly interventionist government policy — than relying on shaky indicators like the stock market and railcar loadings.

This is different than a one - for - one model in that once our developing markets achieve critical mass, they can economically sustain themselves through customer driven demand rather than relying on an influx of donations.

An infographic developed by social - media marketing company NowSourcing details some of the qualities and traits shared by the rich (we're talking those who earn more than $ 160,000 a year and have $ 3.2 million in assets).

Maybe a new fuel - injection system is being developed, one that is superior to and cheaper than what is currently in use, and you know that when it goes into production, it will take up a large share of the market.

In commodity markets silver offers greater leverage than gold and the current developing precious metals breakout is most profitably traded with silver.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

In general, companies from emerging markets invest more, and more often, than their counterparts in the developed world: between 1999 and 2008, emerging - market companies paid out half as much in dividends, but invested much more in fixed assets.

In developed Asia and in developing markets, executives are more likely than others to believe external - affairs issues will boost their operating income in the coming years (Exhibit 2).

While many do have slightly higher expense ratios than their developed - market peers — a reflection of the higher cost of investing in these markets — that is not always the case.

As part of a long - term strategy, EM equity funds offer investors the potential for greater returns than they might get if they invest exclusively in developed markets.

FLIA will invest in fixed - and floating - rate bonds from the full range of governmental and corporate issuers representing developed markets other than the U.S..

Putting all this together, the Australian corporate bond market is relatively small in size and is less well developed than corporate bond markets in a number of other countries.

Today, the company announced that it would cease building its pricey OZO virtual reality cameras after finding that the VR market was developing «slower than expected».

Collectively, they provide detailed equity market coverage for more than 80 countries across developed, emerging and frontier markets, representing 99 % of these investable opportunity sets.

At one level, most of these businesses appear to be success stories: On average, these companies grew profits in their developing market subsidiaries by 15 % a year from 2005 to 2010, more than twice the profit growth rate in the rest of the business.

Rather than focusing on the turbulence, wondering whether you need to do something now or wondering what the market will do tomorrow, it makes more sense to focus on developing and maintaining a sound investing plan.

«As a marketing consultant, copywriter and merchandiser, I know firsthand, (1) that a profitable long term business hinges on strong customer relationships and repeat business, and (2) how much harder it is to develop a new customer than to please an existing one.

PepsiCo Inc reported better - than - expected quarterly revenue on Thursday as double - digit growth in developing markets offset another quarter of weak results in its North American beverage unit.

MarketCap / GVA is better correlated with actual subsequent S&P 500 total returns than price / forward earnings, the Fed Model, the Shiller P / E, price / book, price / dividend, Tobin's Q, market capitalization to GDP, price / revenue and every other valuation ratio we've developed or examined in market cycles across history.

In other words, when developed markets enjoy a cyclical bout of reflationary growth, they have historically had a bigger growth impact on China and EM economies than when developed market economies are weak.